Esa1 Activators consist of a diverse set of compounds that facilitate Esa1 activity by altering the chromatin landscape, modifying competing enzymatic activities, or shifting the balance between acetylation and deacetylation processes. These activators operate within the intricate network of histone modification, exploiting the dynamic nature of chromatin to indirectly potentiate the function of Esa1. Compounds like trichostatin A and sodium butyrate enhance the acetylation status of chromatin, creating an environment in which Esa1 can more effectively exert its acetyltransferase activity. This is not through direct stimulation of Esa1 itself but by reducing the activity of deacetylases that would otherwise oppose Esa1's action.
By inhibiting the removal of acetyl groups via histone deacetylase inhibitors like SAHA or nicotinamide, the balance is tipped in favor of acetylation, thereby facilitating Esa1's role in transcriptional activation. Other compounds, such as anacardic acid or garcinol, may have a more nuanced role, targeting negative regulators or competing pathways to bolster Esa1's activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can increase histone acetylation, potentially enhancing the activity of Esa1 by increasing the pool of acetylated histones available for further acetylation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Another histone deacetylase inhibitor, it can indirectly enhance Esa1 activity by elevating global acetylation levels, facilitating a more open chromatin state. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
As an inhibitor of the sirtuin family of deacetylases, it can augment Esa1 activity indirectly by preventing the deacetylation of histones. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known for its interaction with sirtuin pathways, it could indirectly influence Esa1 by modulating histone acetylation dynamics. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A potent histone deacetylase inhibitor that could complement Esa1's acetyltransferase activity. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A specific histone deacetylase inhibitor which, by inhibiting HDAC activity, could indirectly enhance the acetyltransferase activity of Esa1. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
A histone methyltransferase inhibitor that could indirectly affect Esa1 activity by altering chromatin states. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
A competitive inhibitor of p300/CBP histone acetyltransferases that might boost Esa1 activity by reducing competition for acetyl-CoA substrates. | ||||||